chlorpromazine has been researched along with nalidixic acid in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (23.53) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 3 (17.65) | 29.6817 |
2010's | 8 (47.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Bailey, AM; Paulsen, IT; Piddock, LJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Dalvie, D; Loi, CM; Smith, DA | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Yamabe, S | 1 |
Gomez, EC; Isseroff, RR; Lasarow, RM | 1 |
Onodera, T; Tawara, K; Wagai, N; Yamaguchi, F | 1 |
Epstein, JH; Wintroub, BU | 1 |
Barg, TsM | 1 |
Mizushima, T; Natori, S; Sekimizu, K | 1 |
3 review(s) available for chlorpromazine and nalidixic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Photosensitivity due to drugs.
Topics: Anti-Inflammatory Agents; Chlorpromazine; Dermatitis, Contact; Humans; Nalidixic Acid; Photosensitivity Disorders; Tetracyclines | 1985 |
[Eye complications during use of various medicinal substances with general effects (review of the literature)].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Anti-Bacterial Agents; Antimalarials; Cardiac Glycosides; Cataract; Child; Chloroquine; Chlorpromazine; Epinephrine; Ethambutol; Ethchlorvynol; Eye Diseases; Female; Humans; Miotics; Nalidixic Acid; Phosphates; Pilocarpine; Quinolines; Retinal Degeneration; Warfarin | 1969 |
14 other study(ies) available for chlorpromazine and nalidixic acid
Article | Year |
---|---|
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
Topics: Anti-Bacterial Agents; Antipsychotic Agents; Bacterial Proteins; Base Sequence; Chlorpromazine; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethidium; Gene Expression; Genes, Bacterial; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Oligonucleotide Array Sequence Analysis; Phenothiazines; Salmonella typhimurium; Trans-Activators | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Synergistic effects of chlorpromazine and perphenazine on several chemotherapeutic agents. I. General profile of the effects measured by the filter paper strip-agar diffusion method with Escherichia coli and Pseudomonas aeruginosa.
Topics: Adenosine Triphosphatases; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cefazolin; Chlorpromazine; Deoxyribonucleases; DNA, Bacterial; Drug Synergism; Escherichia coli; Immunodiffusion; Methods; Nalidixic Acid; Perphenazine; Pseudomonas aeruginosa | 1978 |
Quantitative in vitro assessment of phototoxicity by a fibroblast-neutral red assay.
Topics: Cells, Cultured; Chlorpromazine; Doxycycline; Fibroblasts; Humans; Lysosomes; Male; Nalidixic Acid; Neutral Red; Photosensitivity Disorders; Tetracycline | 1992 |
Studies on experimental conditions for detecting phototoxic potentials of drugs in Balb/c mice.
Topics: Animals; Chlorpromazine; Female; Mice; Mice, Inbred BALB C; Nalidixic Acid; Photosensitivity Disorders; Ultraviolet Rays | 1989 |
Relaxation of supercoiled DNA associated with induction of heat shock proteins in Escherichia coli.
Topics: Bacterial Proteins; Chaperonin 60; Chlorpromazine; DNA, Superhelical; Escherichia coli; Escherichia coli Proteins; Ethanol; Genes, Bacterial; Heat-Shock Proteins; Hot Temperature; HSP70 Heat-Shock Proteins; Kinetics; Nalidixic Acid; Novobiocin; Time Factors; Topoisomerase II Inhibitors | 1993 |